Concepedia
Statistics
Publications
3
Citations
190
H-Index
Active since
1999
Affiliations
Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)
Sheba Medical Center
Ministry of Health of the Russian Federation
A. Arkhipov is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, oncology, and medicine.
Publications per year
1999–2024
Multicenter, Phase II Trial of Exemestane as Third-Line Hormonal Therapy of Postmenopausal Women With Metastatic Breast Cancer
Stefanie A Jones, Charles L. Vogel, A. Arkhipov et al. · Journal of Clinical Oncology · 1999 · 113 citations
Medicine, Oncology, Pharmacology +17
Pembrolizumab plus chemotherapy for advanced and recurrent cervical cancer: final analysis according to bevacizumab use in the randomized KEYNOTE-826 study
D. Lorusso, Nicoletta Colombo, Coraline Dubot et al. · Annals of Oncology · 2024 · 49 citations · Full text
Medicine, Oncology, Pharmacology +13
Pembrolizumab in patients with MSI-H advanced endometrial cancer from the KEYNOTE-158 study
David M. O’Malley, Aurélien Marabelle, Ana De Jesus‐Acosta et al. · Annals of Oncology · 2019 · 28 citations · Full text
Medicine, Oncology, Pharmacology +5
1–3 of 3